BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
-0.42%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$137M
AUM Growth
+$137M
Cap. Flow
+$2.64M
Cap. Flow %
1.92%
Top 10 Hldgs %
73.24%
Holding
64
New
1
Increased
15
Reduced
6
Closed
4

Top Buys

1
OVV icon
Ovintiv
OVV
$2.21M
2
PHR icon
Phreesia
PHR
$1.82M
3
PRTA icon
Prothena Corp
PRTA
$1.64M
4
BDSX icon
Biodesix
BDSX
$903K
5
MASI icon
Masimo
MASI
$784K

Top Sells

1
BIIB icon
Biogen
BIIB
$2.13M
2
BMY icon
Bristol-Myers Squibb
BMY
$2.03M
3
AMRN
Amarin Corp
AMRN
$987K
4
UTHR icon
United Therapeutics
UTHR
$707K
5
VNDA icon
Vanda Pharmaceuticals
VNDA
$566K

Sector Composition

1 Healthcare 93.73%
2 Energy 3.94%
3 Consumer Staples 0.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
INBX
26
DELISTED
Inhibrx, Inc. Common Stock
INBX
$800K 0.58%
70,448
+20,000
+40% +$227K
TSVT
27
DELISTED
2seventy bio
TSVT
$790K 0.57%
59,833
+25,500
+74% +$337K
DCGO icon
28
DocGo
DCGO
$153M
$785K 0.57%
110,000
– –
SLNO icon
29
Soleno Therapeutics
SLNO
$3.6B
$680K 0.49%
3,676,899
– –
NARI
30
DELISTED
Inari Medical, Inc. Common Stock
NARI
$680K 0.49%
10,000
+2,000
+25% +$136K
IMGN
31
DELISTED
Immunogen Inc
IMGN
$675K 0.49%
150,000
-40,000
-21% -$180K
ARVN icon
32
Arvinas
ARVN
$568M
$631K 0.46%
15,000
– –
CFRX
33
DELISTED
ContraFect Corporation
CFRX
$614K 0.45%
200,000
– –
TPTX
34
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$602K 0.44%
8,000
– –
CGEM icon
35
Cullinan Oncology
CGEM
$445M
$578K 0.42%
45,114
– –
APLS icon
36
Apellis Pharmaceuticals
APLS
$3.48B
$543K 0.4%
12,000
– –
CCXI
37
DELISTED
ChemoCentryx, Inc.
CCXI
$496K 0.36%
20,000
– –
NKTR icon
38
Nektar Therapeutics
NKTR
$568M
$486K 0.35%
128,000
– –
IRTC icon
39
iRhythm Technologies
IRTC
$5.46B
$432K 0.31%
4,000
– –
FOLD icon
40
Amicus Therapeutics
FOLD
$2.34B
$408K 0.3%
38,000
– –
BLUE
41
DELISTED
bluebird bio
BLUE
$406K 0.3%
98,000
+14,000
+17% +$58K
VTYX icon
42
Ventyx Biosciences
VTYX
$171M
$404K 0.29%
33,000
+8,000
+32% +$97.9K
KALV icon
43
KalVista Pharmaceuticals
KALV
$678M
$394K 0.29%
40,000
– –
SILK
44
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$364K 0.26%
10,000
– –
XNCR icon
45
Xencor
XNCR
$580M
$337K 0.25%
12,300
– –
XENE icon
46
Xenon Pharmaceuticals
XENE
$2.98B
$304K 0.22%
+10,000
New +$304K
PTGX icon
47
Protagonist Therapeutics
PTGX
$3.67B
$301K 0.22%
38,000
– –
KNSA icon
48
Kiniksa Pharmaceuticals
KNSA
$2.48B
$291K 0.21%
30,000
– –
ZNTL icon
49
Zentalis Pharmaceuticals
ZNTL
$122M
$225K 0.16%
8,000
– –
BCRX icon
50
BioCryst Pharmaceuticals
BCRX
$1.74B
$212K 0.15%
20,000
– –
1
2
3